Literature DB >> 20607864

Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.

A Kodam1, M Maulik, K Peake, A Amritraj, K S Vetrivel, G Thinakaran, J E Vance, S Kar.   

Abstract

Niemann-Pick type C (NPC) disease is an autosomal recessive neurodegenerative disorder characterized by intracellular accumulation of cholesterol and glycosphingolipids in many tissues including the brain. The disease is caused by mutations of either NPC1 or NPC2 gene and is accompanied by a severe loss of neurons in the cerebellum, but not in the hippocampus. NPC pathology exhibits some similarities with Alzheimer's disease, including increased levels of amyloid beta (Abeta)-related peptides in vulnerable brain regions, but very little is known about the expression of amyloid precursor protein (APP) or APP secretases in NPC disease. In this article, we evaluated age-related alterations in the level/distribution of APP and its processing enzymes, beta- and gamma-secretases, in the hippocampus and cerebellum of Npc1(-/-) mice, a well-established model of NPC pathology. Our results show that levels and expression of APP and beta-secretase are elevated in the cerebellum prior to changes in the hippocampus, whereas gamma-secretase components are enhanced in both brain regions at the same time in Npc1(-/-) mice. Interestingly, a subset of reactive astrocytes in Npc1(-/-) mouse brains expresses high levels of APP as well as beta- and gamma-secretase components. Additionally, the activity of beta-secretase is enhanced in both the hippocampus and cerebellum of Npc1(-/-) mice at all ages, while the level of C-terminal APP fragments is increased in the cerebellum of 10-week-old Npc1(-/-) mice. These results, taken together, suggest that increased level and processing of APP may be associated with the development of pathology and/or degenerative events observed in Npc1(-/-) mouse brains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607864      PMCID: PMC2914615          DOI: 10.1002/glia.21001

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  58 in total

1.  Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene.

Authors:  S K Loftus; J A Morris; E D Carstea; J Z Gu; C Cummings; A Brown; J Ellison; K Ohno; M A Rosenfeld; D A Tagle; P G Pentchev; W J Pavan
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

2.  Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis.

Authors:  E D Carstea; J A Morris; K G Coleman; S K Loftus; D Zhang; C Cummings; J Gu; M A Rosenfeld; W J Pavan; D B Krizman; J Nagle; M H Polymeropoulos; S L Sturley; Y A Ioannou; M E Higgins; M Comly; A Cooney; A Brown; C R Kaneski; E J Blanchette-Mackie; N K Dwyer; E B Neufeld; T Y Chang; L Liscum; J F Strauss; K Ohno; M Zeigler; R Carmi; J Sokol; D Markie; R R O'Neill; O P van Diggelen; M Elleder; M C Patterson; R O Brady; M T Vanier; P G Pentchev; D A Tagle
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

3.  Staining of cholesterol with the fluorescent antibiotic "filipin".

Authors:  H Börnig; G Geyer
Journal:  Acta Histochem       Date:  1974       Impact factor: 2.479

4.  Trafficking of cholesterol from cell bodies to distal axons in Niemann Pick C1-deficient neurons.

Authors:  Barbara Karten; Dennis E Vance; Robert B Campenot; Jean E Vance
Journal:  J Biol Chem       Date:  2002-11-27       Impact factor: 5.157

5.  Differential distribution of amyloid protein precursor immunoreactivity in the rat brain studied by using five different antibodies.

Authors:  J G Beeson; E R Shelton; H W Chan; F H Gage
Journal:  J Comp Neurol       Date:  1994-04-01       Impact factor: 3.215

6.  Studies on neuronal death in the mouse model of Niemann-Pick C disease.

Authors:  Robert P Erickson; Ora Bernard
Journal:  J Neurosci Res       Date:  2002-06-15       Impact factor: 4.164

7.  Glial expression of the beta-amyloid precursor protein (APP) in global ischemia.

Authors:  R B Banati; J Gehrmann; C Wiessner; K A Hossmann; G W Kreutzberg
Journal:  J Cereb Blood Flow Metab       Date:  1995-07       Impact factor: 6.200

8.  Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease.

Authors:  Justyna R Sarna; Matt Larouche; Hassan Marzban; Roy V Sillitoe; Derrick E Rancourt; Richard Hawkes
Journal:  J Comp Neurol       Date:  2003-02-10       Impact factor: 3.215

Review 9.  Alzheimer's disease: the cholesterol connection.

Authors:  Luigi Puglielli; Rudolph E Tanzi; Dora M Kovacs
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

10.  Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.

Authors:  Maike Hartlage-Rübsamen; Ulrike Zeitschel; Jenny Apelt; Ulrich Gärtner; Heike Franke; Tobias Stahl; Albrecht Günther; Reinhard Schliebs; Milena Penkowa; Volker Bigl; Steffen Rossner
Journal:  Glia       Date:  2003-01-15       Impact factor: 7.452

View more
  20 in total

1.  Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

Authors:  Niklas Mattsson; Henrik Zetterberg; Simona Bianconi; Nicole M Yanjanin; Rao Fu; Jan-Eric Månsson; Forbes D Porter; Kaj Blennow
Journal:  JIMD Rep       Date:  2011-09-28

Review 2.  Astrocytes and lysosomal storage diseases.

Authors:  K V Rama Rao; T Kielian
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

3.  Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Authors:  Niklas Mattsson; Maria Olsson; Mikael K Gustavsson; Marko Kosicek; Martina Malnar; Jan-Eric Månsson; Maria Blomqvist; Johan Gobom; Ulf Andreasson; Gunnar Brinkmalm; Charles Vite; Silva Hecimovic; Caroline Hastings; Kaj Blennow; Henrik Zetterberg; Erik Portelius
Journal:  Metab Brain Dis       Date:  2012-09-01       Impact factor: 3.584

4.  APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

Authors:  Mahua Maulik; Kyle Peake; JiYun Chung; Yanlin Wang; Jean E Vance; Satyabrata Kar
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

5.  Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells.

Authors:  J Chung; G Phukan; D Vergote; A Mohamed; M Maulik; M Stahn; R J Andrew; G Thinakaran; E Posse de Chaves; S Kar
Journal:  Mol Cell Biol       Date:  2018-05-15       Impact factor: 4.272

Review 6.  Rab GTPases implicated in inherited and acquired disorders.

Authors:  Shreya Mitra; Kwai W Cheng; Gordon B Mills
Journal:  Semin Cell Dev Biol       Date:  2010-12-13       Impact factor: 7.727

Review 7.  Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis.

Authors:  M Maulik; D Westaway; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2012-09-16       Impact factor: 5.590

8.  APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.

Authors:  Elisabet Barbero-Camps; Anna Fernández; Laura Martínez; Jose C Fernández-Checa; Anna Colell
Journal:  Hum Mol Genet       Date:  2013-05-06       Impact factor: 6.150

Review 9.  The role of cholesterol metabolism in Alzheimer's disease.

Authors:  Jia-Hao Sun; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-18       Impact factor: 5.590

10.  Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing Aβ Generation and Amyloid Plaque Pathogenesis.

Authors:  Qingli Xiao; Ping Yan; Xiucui Ma; Haiyan Liu; Ronaldo Perez; Alec Zhu; Ernesto Gonzales; Danielle L Tripoli; Leah Czerniewski; Andrea Ballabio; John R Cirrito; Abhinav Diwan; Jin-Moo Lee
Journal:  J Neurosci       Date:  2015-09-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.